Open AccessRisk of Bleeding With Dabigatran in Atrial Fibrillation
Author(s) -
Inmaculada Hernandez,
Seo Hyon Baik,
Antonio Piñera,
Yuting Zhang
Publication year - 2014
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2014.5398
Subject(s) - medicine , dabigatran , warfarin , atrial fibrillation , gastrointestinal bleeding , retrospective cohort study , hazard ratio , proportional hazards model , prothrombin complex concentrate , confidence interval
It remains unclear whether dabigatran etexilate mesylate is associated with higher risk of bleeding than warfarin sodium in real-world clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom